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AMP-activated kinase (AMPK) is activated in response to
metabolic stresses that deplete cellular ATP, and in both liver
and skeletal muscle, activated AMPK stimulates fatty acid
oxidation. To determine whether AMPK might reciprocally
regulate glycerolipid synthesis, we studied liver and skeletal-
muscle lipid metabolism in the presence of 5-amino-4-
imidazolecarboxamide (AICA) riboside, a cell-permeable com-
pound whose phosphorylated metabolite activates AMPK.
Adding AICA riboside to cultured rat hepatocytes for 3 h
decreased ["%C]oleate and [$H]glycerol incorporation into triacyl-
glycerol (TAG) by 50% and 38% respectively, and decreased
oleate labelling of diacylglycerol by 60%. In isolated mouse
soleus, a highly oxidative muscle, incubation with AICA riboside
for 90 min decreased ["%C]oleate incorporation into TAG by
37% and increased "%CO
#
production by 48%. When insulin was
present, ["%C]oleate oxidation was 49% lower and ["%C]oleate
incorporation into TAG was 62% higher than under basal
conditions. AICA riboside blocked insulin ’s antioxidative and
lipogenic effects, increasing fatty acid oxidation by 78% and
INTRODUCTION
After entering cells, long-chain fatty acid is converted into acyl-
CoA, which may then be either β-oxidized or esterified into
complex lipids, including triacylglycerol (TAG). Adjustments in
acyl-CoA partitioning between oxidative and biosynthetic path-
ways are critical responses during metabolic stresses that deplete
energy, such as exercise and starvation. In response to energy
depletion, fatty acid oxidation is increased, and one may predict
that fatty acid storage in the form of TAG would be reciprocally
decreased. AMP-activated protein kinase (AMPK) is a probable
mediator of acyl-CoA partitioning into glycerolipid synthesis
versus β-oxidation.
AMPK belongs to a family of highly conserved serine kinases
that are regulated by metabolic and nutritional stresses that
increase cellular AMP concentrations [1]. AMP allosterically
activates AMPK and potentiates AMPK activity by stimulating
an upstream kinase, AMPK kinase, which phosphorylates and
activates AMPK [2]. In addition, the binding of AMP to AMPK
renders the kinase a better substrate for its activator,
Abbreviations used: ACC, acetyl-CoA carboxylase ; ACS, acyl-CoA synthetase ; AICA, 5-amino-4-imidazolecarboxamide; AMPK, AMP-activated
kinase ; ASM, acid-soluble metabolites ; CPT1, carnitine palmitoyltransferase 1; DAG, diacylglycerol ; DGAT, diacylglycerol acyltransferase ; DMEMH,
Dulbecco’s modified high-glucose Eagle’s medium; FBS, fetal bovine serum; GPAT, sn-glycerol-3-phosphate acyltransferase ; HMG-CoA, 3-hydroxy-
3-methylglutaryl-CoA; MEM, minimal essential medium; NEM, N-ethylmaleimide ; TAG, triacylglycerol.
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decreasing labelled TAG 43%. Similar results on fatty acid









also inhibited the hydrolysis of intracellular TAG. These data
suggest that AICA riboside might inhibit sn-glycerol-3-phosphate
acyltransferase (GPAT), which catalyses the committed step in
the pathway of glycerolipid biosynthesis. Incubating rat
hepatocyteswith AICA riboside for both 15 and 30 min decreased
mitochondrial GPAT activity 22–34% without affecting micro-
somal GPAT, diacylglycerol acyltransferase or acyl-CoA
synthetase activities. Finally, purified recombinant AMPKα1
and AMPKα2 inhibited hepatic mitochondrial GPAT in a time-
and ATP-dependent manner. These data show that AMPK
reciprocally regulates acyl-CoA channelling towards β-oxidation
and away from glycerolipid biosynthesis, and provide strong
evidence that AMPK phosphorylates and inhibits mitochondrial
GPAT.
Key words: lipid partitioning, hepatocytes, myocytes.
AMPK kinase, and a worse substrate for protein phosphatases
that might inactivate it [3]. In itro, high concentrations of ATP
antagonize the stimulation of AMPK by AMP, and therefore the
cellular ratio of AMP:ATP appears to be the primary regulator
of AMPK activity.
It has been suggested that the AMPK system evolved to
protect the cell against ATP depletion by inhibiting biosynthetic
pathways and stimulating energy-generating pathways [1]. In
keeping with this model, AMPK phosphorylates and inactivates
liver acetyl-CoA carboxylase (ACC), 3-hydroxy-3-methyl-
glutaryl-CoA (HMG-CoA) reductase, glycogen synthase [4,5]
and creatine kinase [6], enzymes that control the synthesis of
fatty acids, cholesterol, glycogen and phosphocreatine respect-
ively. The product of ACC, malonyl-CoA, is both a precursor for
the biosynthesis of fatty acids and a potent inhibitor of β-
oxidation because it inhibits carnitine palmitoyltransferase I
(CPT1) and, thereby, the transport of long-chain fatty acids into
the mitochondrial matrix [7]. Thus when ACC is inactivated,
cellular concentrations of malonyl-CoA decrease, the inhibition
of CPT1 is relieved, and more fatty acid is oxidized. AMPK has
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been shown to increase fatty acid oxidation in liver, heart and
skeletal muscle, the primary tissues that oxidize fatty acids [8,9].
We hypothesized that AMPK would also inactivate one or
more of the enzymes of glycerolipid biosynthesis, thereby
inhibiting TAG synthesis and promoting the partitioning of fatty
acyl-CoA towards β-oxidation. To test our hypothesis, we
incubated liver and muscle with 5-aminoimidazole-4-carbox-
amide (AICA) riboside, a cell-permeable compound that is
metabolized to its monophosphorylated derivative, ZMP (an
AMP analogue), which mimics the multiple stimulatory effects
of AMP as an activator of AMPK [10]. We provide direct
evidence that AMPK inhibits the mitochondrial isoform of sn-
glycerol-3-phosphate acyltransferase (GPAT), the enzyme that
catalyses the initial and committed step in glycerolipid bio-
synthesis. GPAT appears to represent a novel target of AMPK,
whose inhibition decreases the de noo synthesis of TAG and
phospholipids. By inactivating both ACC and GPAT, AMPK
would regulate the partitioning of fatty acid between oxidative




[$H]Glycerol and ["%C]oleate were obtained from Amersham Life
Sciences Co. (Arlington, IL, U.S.A.). AICA riboside, BSA
(essentially fatty-acid-free), glucose, carnitine, sodium oleate and
horse serum were from Sigma (St. Louis, MO, U.S.A.). Silica-gel
plates and filter paper were from Whatman (Maidstone, Kent,
U.K.). Tissue culture supplies and fetal bovine serum (FBS) were
from Life Technologies, Inc. (Gaithersburg, MD, U.S.A.).
Animals
All animal protocols were approved by the University of North
Carolina at Chapel Hill Institutional Animal Care and Use
Committee. Hepatocytes were isolated from livers of male
Sprague–Dawley rats (200–250 g). Soleus muscles were isolated
from female C57BL}6J mice (Jackson Laboratory, Bar Harbor,
ME, U.S.A.). Animals were maintained on a 12-h}12-h light}
dark cycle with free access to Purina mouse chow, which was
removed from the animals’ cages at 09:00h during the experi-
ments.
Hepatocyte isolation and incubations
Hepatocytes were isolated by collagenase perfusion [11]. Cell
viability, determined by Trypan Blue exclusion, always exceeded
95%. Hepatocytes were seeded at a density of 200000 cells}well
into 24-well dishes (Becton Dickinson and Co., Lincoln Park,
NJ, U.S.A.) that had been pretreated with 0.01% (w}v) rat-tail
collagen in 0.1 Macetic acid, and cultured at 37 °C in a humidified
atmosphere of 5% CO
#
in 2.0 ml of minimal essential medium
(MEM) containing 10% (v}v) heat-inactivated FBS, 50 units}ml
penicillin and 50 µg}ml streptomycin. After cells had attached
for 3–4 h, media was replaced with serum-free MEM plus 10 nM
dexamethasone and 0.1 mM non-essential amino acids, and
hepatocytes were cultured overnight. Experiments were per-
formed the following morning in media with serum-free MEM
containing 10 nM dexamethasone, 10 mM Hepes, 1.0 mM
carnitine, 0.5% (w}v) fatty-acid-free BSA and 0.2 mM sodium
oleate, with either ["%C]oleate (0.8 µCi}mM) or 0.5 mmol}ml
[$H]glycerol (1.0 Ci}mM) in the presence or absence of 0.5 mM
AICA riboside. After 1–3 h, the media were transferred to new
dishes and assayed for labelled oxidation products [CO
#
and
acid-soluble metabolites (ASM)]. Hepatocytes were washed twice
with 1% (w}v) BSA in PBS at 37 °C, scraped in two additions of
0.5 ml of ice-cold methanol and 0.5 ml of water, and total cell
lipids were extracted [12]. In pulse–chase experiments, cells were
labelled for 12 h in media containing 0.2 mM ["%C]oleate (as
above), washed twice, and then incubated for 3 h in media
containing 0.2 mM unlabelled sodium oleate in the presence or
absence of 0.5 mM AICA riboside. Media and cells were collected
and analysed as described above.
In cell-suspension experiments, hepatocytes (750000 cells}ml)
were incubated in Krebs–Henseleit Buffer bicarbonate buffer}
5.0 mM glucose}1.0 mM carnitine}1% (w}v) BSA, with 0.2 mM
["%C]oleate (0.8 µCi}mM). Incubations for 1–2 h in the absence
or presence of 0.5 mM AICA riboside were performed in a total
volume of 1.5 ml of media in 24-well dishes that were agitated in




(19:1). To terminate the experiments, cells were transferred to
1.5 ml of ice-cold microcentrifuge tubes and centrifuged for
3 min at 3000 rev.}min (1600 g) at 5 °C. The cell pellet was
washed twice with 1% (w}v) BSA in PBS and added to 0.5 ml of
ice-cold methanol for lipid extraction [12]. In separate dishes,
incubations were terminated by adding 100 ml of 70% (v}v)










from the American Type Culture Collection (Rockville, MD,
U.S.A.) were grown in Dulbecco’s modified high-glucose Eagle’s
medium (DMEMH; 90%)}10% (v}v) FBS}4.0 mM glutamine}
50 µg}ml gentamycin, in a humidified incubator at 37 °C, 5%
CO
#
. Cells were grown in 100-mm dishes, subcultured at 60–
80% confluence, and split at a ratio of 1:10 using trypsin [0.25%
(w}v) in MEM with 1.0 mM EDTA]. Cells grown to
60% confluence were subcultured at a ratio of 1:15 into 6-well
dishes thathadbeencoatedwith0.01% (w}v) collagen.Whencells
were 80% confluent, myoblasts were induced to differentiate
into myotubes by changing to low-serum differentiation medium
[98% DMEMH}2% (v}v) horse serum}4.0 mM glutamine}
25 mM Hepes}50 µg}ml gentamycin]. Differentiation medium
was changed daily. By day 5, cells were fully confluent and had
differentiated into multinucleated, contracting myotubes.
Myocytes maintained in differentiation medium for 0 (myo-
blasts) or 5–6 days (myotubes) were preincubated for 1 h in
serum-free MEM}12.0 mM glucose}4.0 mM glutamine}25 mM
Hepes}1% (w}v) BSA}0.25 mM oleate}50 µg}ml gentamycin.
Preincubation medium was replaced with 1.0 ml of fresh media
containing ["%C]oleate (1.0 µCi}mM), and cells were incubated
for 2 h at 37 °C in the absence or presence of 1.0 mM AICA
riboside and 10−( M insulin. Incubations were terminated by
removing the media, which were subsequently assayed for "%C-
labelled oxidation products (see below). The cells were washed
twice with 1% (w}v) BSA in PBS at 37 °C, scraped in two
additions of 1.0 ml of ice-cold methanol and 0.5 ml of water, and
lipids were extracted [12]. For pulse–chase experiments, cells
were pre-labelled for 3 h in pulse media containing 0.25 mM
["%C]oleate, as described above. Cells were washed twice with 1%
(w}v) BSA in PBS, and then incubated for 3 h in chase media
containing 0.25 mM unlabelled sodium oleate in the presence or
absence of 1.0 mM AICA riboside. Media and cells were collected
and analysed as described above.
Muscle isolation and incubations
Mouse soleus muscles were removed between 09:00h and 11:00h
under anaesthesia (100 mg}kg ketamine and 10 mg}kg xylazine),
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cleaned free of adipose and connective tissue, and immediately
transferred to a 24-well tissue-culture dish in a shaking water
bath at 29 °C. Each well contained 1.0 ml of a modified Krebs–
Ringer bicarbonate buffer (KRB) [low-calcium Kreb’s Henseleit
bicarbonate buffer}1.0% (w}v) dialysed BSA}5.0 mM glucose],





muscles were isolated, they were incubated for an additional
15 min at 37 °C, before being transferred to fresh KRB medium
containing oleate (1.0–1.5 mM), 1.0 mM carnitine and 1% (w}v)
BSA (KRB­fatty acid medium) and, where indicated, 10−( M
insulin. Muscles were incubated for 20 min in KRB­fatty acid
medium, and then transferred to fresh KRB­fatty acid medium
containing ["%C]oleate (1.0 µCi}ml) and, where indicated, 10−( M
insulin. High oleate concentrations were used in order to inhibit
lipolysis of intramuscular TAG, and thereby minimize label
dilution. AICA riboside (0.5–2.0 mM) was added to half the
muscles, and the contralateral muscle from each mouse was used
as a basal (non-treated) control. Following a 90 min incubation,
muscles were washed twice in ice-cold KRB for 10 min, weighed
and immediately frozen at ®80 °C until extracted for lipids.
Incubation medium was then assayed for oxidation products as
described below.
Determination of fatty acid partitioning
To assay oxidation products, semi-dry filter paper (Whatman
g3) saturated with 2 MNaOH was placed over 24-well incubation
dishes and tightly covered with a foam pad and the plate cover.
"%CO
#
produced by muscles or cells was driven from the media to
the filter-paper trap by adding 100 µl of 70% (v}v) perchloric
acid to each well. After 60 min in a shaking bath at 37 °C, the
filter paper discs corresponding to each well were dried, cut and
washed in 2.0 ml of distilled water. "%CO
#
was quantified in
1.0-ml aliquots of the water wash. ASM, a measure of ketone
bodies in the liver and of tricarboxylic-acid-cycle intermediates
and acetyl esters in muscle [13], were assayed in supernatants of
the acid precipitate. In hepatocytes, ASM routinely accounted for
over 90% of total oxidation products. Minimal increases in "%C
over background levels occurred in media in which muscles or
myocytes had been incubated, indicating that insignificant
amounts (! 15% of the counts recovered as CO
#
) of ASM had
been released into the medium.
Lipids were extracted from muscles or cells and TAG, diacyl-
glycerol (DAG), phospholipids and fatty acids were separated by
thin-layer chromatography on scored silica gel G plates in
hexane:diethyl ether :acetic acid (80:20:1, v}v) [14]. Radio-
activity incorporated into different lipid species was determined
by comparison with standards using a Bioscan 200 system.
Enzyme extraction and assays
To measure enzyme activities, hepatocytes were diluted to a
density of 10( cells}ml in media identical with that of the
hepatocyte suspensions, including 0.2 mM unlabelled oleate. A
fraction of the cell suspension (2 ml) was incubated for 0–90 min





(19:1). Incubations were terminated by adding
the cells to 1.0 ml of 3¬homogenization buffer (0.75 mM su-
crose}30 mM Tris base}3.0 mM EDTA}3.0 mM dithiothreitol}
150 mM sodium fluoride}12 mM sodium pyrophosphate) at
pH 7.4, and then quickly frozen in a 95% ethanol}dry-ice slurry.
As cells thawed they were homogenized in a motor-driven Teflon–
glass homogenizer using 10 up-and-down strokes. Homogenates
were centrifuged at 100000 g for 60 min. The total particulate
pellet was re-homogenized using 5 up-and-down strokes in
homogenization buffer, and aliquots were stored at ®80 °C until
enzyme assays were performed. Mitochondrial fractions from rat
liver were obtained by differential centrifugation [15].
Total GPAT activity was measured with 300 µM [$H]glycerol
3-phosphate and 25 µM palmitoyl-CoA [16]. The mitochondrial
GPAT activity was measured after incubating membranes for
15 min on ice with N-ethylmaleimide (NEM). NEM inhibits
microsomal GPAT, but not mitochondrial GPAT [17]. NEM-
resistant GPAT activity (mitochondrial) was subtracted from the
total activity to determine microsomal GPAT activity. Diacyl-
glycerol acyltransferase (DGAT) activity was measured with
30 µM [$H]palmitoyl-CoA and 200 µM sn-1,2-dioleoylglycerol
[18]. Acyl-CoA synthetase (ACS) was measured with 50 µM
[$H]palmitate}10 mM ATP}0.2 mM CoA [19].
AMPK inhibition
AMPK heterotrimers, containing either α-1 or α-2 catalytic
subunits and with β-1 and γ-1 non-catalytic subunits, were
isolated after cDNA expression in COS-7 cells [20]. Rat liver
mitochondria (150 µg of protein) were incubated with AMPK1
or AMPK2 [20] in 0.2 mM AMP}5.0 mM MgCl
#
}120 mM
NaCl}80 mM Hepes, pH 7.0, for 10–30 min at 30 °C in the
presence or absence of 1.3 mM ATP, before being assayed for
GPAT activity.
Other methods
CellularDNAcontentwas measured fluorimetrically [21]. Protein
concetration was measured using BSA as the standard [22].
[$H]Glycerol 3-phosphate [23] and [$H]palmitoyl-CoA [24] were
synthesized enzymically.
Statistics
Data from muscle incubations are presented as means³S.E.M.
Differences between basal and AICA riboside-treated contra-
lateral muscles were analysed by paired Student ’s t test at the
P! 0.05 level. All other data are presented as means³S.D. and
were analysed by either Student’s t test or by two-way
(treatment¬time) analysis of variance. Statistically significant
differences between hormone treatments were detected by
Newman–Keuls’ post-hoc test.
RESULTS
AMPK regulates glycerolipid metabolism in hepatocytes
When primary rat hepatocytes in monolayer culture were incu-
bated with either ["%C]oleate or [$H]glycerol, oleate incorporation
into complex lipids and oxidation products (ASM­CO
#
)
increased linearly from 0–3 h (Figure 1A). Adding AICA riboside
decreased "%C labelling of TAG at 1 and 3 h by 39% and 50%
respectively (P! 0.001) (Figure 1A), and decreased "%C labelling
of DAG by 29% and 60% (P! 0.001) (Figure 1B). AICA
riboside did not affect ["%C]oleate incorporation into phospho-
lipid (Figure 1A) or cholesterol esters (Figure 1B). Similarly,
AICA riboside decreased [$H]glycerol incorporation into TAG
at 1 and 3 h by 47% and 38% (P! 0.001) respectively, but did
not affect $H labelling of phospholipid (Figure 1C). These data
suggest that AMPK decreases de noo the synthesis of TAG and
its immediate precursor DAG, but without affecting the synthesis
of phospholipid or cholesterol esters. The observation that AICA
riboside neither affected cell viability for up to 6 h (results not
shown) nor decreased all end products provides evidence against
a generalized effect of AICA riboside that would compromise cell
function.
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Figure 1 Effect of AICA riboside on hepatocyte cell cultures
Hepatocyte monolayers were incubated at 37 °C with 0.2 mM [14C]oleate for 1–3 h with or without 0.5 mM AICA riboside (AICAR). Incorporation of [14C]oleate was measured into (A) TAG and
phospholipids (PL), (B) DAG and cholesteryl ester (CE), and (D) oxidation products (ASM­CO2). (C) Hepatocyte monolayers were incubated with 0.2 mM oleate and 0.5 mM [
3H]glycerol for
1–3 h with or without 0.5 mM AICAR, and incorporation of [3H]glycerol was measured into TAG and PL. Values represent means³S.D. for three to six wells, each collected during three separate
incubations.
Because the activities of TAG-biosynthetic enzymes might
decrease with time in cultured hepatocytes, we also tested the
effect of AICA riboside on suspensions of freshly isolated
hepatocytes. At 1 h, AICA riboside decreased ["%C]oleate in-
corporation into TAG, DAG and phospholipid by 47%, 96%
and 45% (P! 0.001) respectively, but did not inhibit labelling of
cholesterol esters (results not shown). The observation that
AICA riboside’s effects on DAG and phospholipid were greater
in freshly isolated hepatocytes than in cultured cells might be
related to hepatocyte de-differentiation and down-regulation of
liver-specific and lipogenic enzymes in cultured hepatocytes.
Interestingly, ["%C]oleate incorporation into cholesterol esters
reached a plateau by 1 h in control cells, but remained linear up
to 2 h in AICA riboside-treated cells, so that, at 2 h, AICA
riboside increased "%C labelling of cholesterol ester by 77% (P!
0.001). This observation suggested the possibility that in control
cells, the rates of cholesterol ester synthesis and hydrolysis were
equal during the second hour of incubation, and that AMPK
might inhibit the hydrolysis of cholesterol esters (as discussed
below).
AICA riboside did not alter the labelling of oxidation products
in hepatocyte suspensions (results not shown). This differs from
a hepatocyte study in which a 10 min incubation with AICA
riboside stimulated long-chain fatty acid oxidation [8]. The
differences between our data and those reported previously is
likely to result from our longer incubation time with ["%C]oleate.
During longer ["%C]oleate incubations, more of the hepatocyte
TAG pool becomes labelled, but because AICA riboside
decreases ["%C]oleate incorporation, the specific activity of the
TAG pool is lower when AICA riboside is present. Because a
large portion of fatty acid oxidized by hepatocytes is derived
from the lipolysis of intracellular TAG (results not shown), a
decrease in TAG-specific activity would mask subsequent stimu-
lation by AICA riboside of fatty acid entry into mitochondria.
When the incubation is longer, there may be no observable effect
on net ["%C]oleate oxidation.
AMPK regulates glycerolipid metabolism in isolated skeletal
muscle
Because AMPK regulates fatty acid oxidation in skeletal muscle
[9], we investigated the effects of AICA riboside in isolated
mouse soleus muscles. During a 90 min incubation, 1.0 mM
AICA riboside increased ["%C]oleate oxidation to CO
#
by 48%
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Figure 2 Effect of AICA riboside in isolated soleus muscles
Mouse soleus muscles were incubated with 1.0 mM [14C]oleate for 90 min at 37 °C with 0,
0.5 or 1.0 mM AICA riboside (AICAR). Incorporation of [14C]oleate into (A) CO2 and (B) TAG
was determined. Muscles were incubated for 90 min with 1.5 mM [14C]oleate plus 10−7 M
insulin, with or without 2.0 mM AICA riboside, and [14C]oleate incorporation into (C) CO2, (D)
TAG and (E) DAG and phospholipids (PL) was determined. (F) Fatty acid partitioning was
quantified for each muscle by dividing the amount of 14C label recovered in TAG by the amount
of [14C]oleate oxidized to CO2. Values represent means³S.E.M. for four to six muscles.
Differences between AICA riboside-treated muscles and contralateral controls were analysed by
paired Student’s t test (*P ! 0.05 ; **P ! 0.005). Differences between controls and insulin-
treated muscles were analysed by single-factor analysis of variance (†P ! 0.05 ; ††P ! 0.005).
(Figure 2A) and decreased ["%C]oleate incorporation into TAG
by 37% (Figure 2B).
In order to investigate the effects of AICA riboside during
incubation conditions that normally promote lipogenesis, and to
determine whether AICA riboside blocks the lipogenic action of
insulin, we incubated soleus muscles in media containing
10−( M insulin and 1.5 mM ["%C]oleate. Consistent with our
previous observations [25], adding insulin to the media decreased
oleate oxidation by 49% and increased oleate incorporation into
TAG by 62% (Figures 2C and 2D respectively). Adding AICA
riboside completely blocked both the antioxidative and the
lipogenic effects of insulin ; fatty acid oxidation increased by
78%, fatty acid labelling of TAG decreased by 43%, and fatty
acid esterification into DAG and phospholipid decreased by
49% and 35% respectively (Figure 2E). The combined effects of
AICA riboside on fatty acid oxidation and fatty acid esterification
resulted in a 71% decrease in the ratio of fatty acid esterified into
TAG}fatty acid oxidized (Figure 2F). These data indicate that
AICA riboside alters muscle fatty acid partitioning between
oxidative and lipogenic pathways, and that AMPK-mediated
Figure 3 Effect of AICA riboside in muscle cell cultures
On day 0 (myoblasts) and day 5 (myotubes) in differentiation media, myocytes were incubated
for 2 h in 0.25 mM [14C]oleate, with or without 1.0 mM AICA riboside (AICAR) and 10−7 M
insulin. [14C]Oleate incorporation into (A) TAG, (B) DAG and (C) CO2 was determined. Values
represent means³S.D. for three to four wells collected during three separate incubations.
Differences between AICA riboside-treated and control cells were detected by Student’s t test
(*P ! 0.05 ; **P ! 0.01). Differences between insulin-treated groups were analysed by single-
factor analysis of variance (†P ! 0.05 ; ††P ! 0.005).
regulation of fatty acid oxidation and glycerolipid metabolism
are reciprocally co-ordinated.
AMPK regulates glycerolipid metabolism in cultured skeletal
muscle cells
To establish a muscle cell model in which to study the mechanism
of AICA riboside-induced regulation of muscle glycerolipid




myocytes, which can be
induced to differentiate from myoblasts into myotubes [26,27].
Although myotubes incorporated 58% less ["%C]oleate into TAG
than did undifferentiated myoblasts (Figure 3A), at both stages
of differentiation AICA riboside increased oleate oxidation by
50–70% (Figure 3C). In undifferentiated myoblasts, AICA
riboside decreased ["%C]oleate incorporation into TAG by 35%,
DAG by 59% (Figures 3A and 3B respectively) and phospholipid
by 26% [for control, 435³45 nmol}mg DNA, and with AICA
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Figure 4 Effect of AICA riboside on lipid hydrolysis in hepatocytes and
muscle cell cultures
(A) After hepatocyte monolayers were labelled for 12 h with 0.2 mM [14C]oleate, they were
incubated at 37 °C for 3 h in chase media containing 0.2 mM oleate with or without 0.5 mM
AICA riboside (AICAR), and 14C label incorporation into TAG, DAG, phospholipids (PL) and
cholesteryl ester (CE) was measured. Data are expressed as a percentage of the label lipids
recovered from cells collected immediately after the 12 h labelling period (in units of
d.p.m./2.0¬105 cells : TAG, 5359³586 ; DAG, 230³35 ; PL, 4855³679 ; CE, 552³67).
(B) After myotubes (day 6 in differentiation media) were labelled for 3 h with 0.25 mM
[14C]oleate, they were incubated for 3 h in chase media containing 0.25 mM oleate with or
without 1.0 mM AICAR. [14C]oleate incorporation into TAG, DAG and PL was measured. Data
are expressed as a percentage of the label lipids recovered from myotubes collected immediately
after the 3 h preincubation (in units of d.p.m./µg DNA : TAG, 1400³113 ; DAG, 130³18 ; PL,
2731³226). Values represent means³S.D. for six wells. Differences between groups were
detected by Student’s t test (*P ! 0.05 ; **P ! 0.001).
riboside, 318³45 nmol}mg DNA (P! 0.005)]. Although
AICA riboside decreased labelling of DAG by 44% in differ-
entiated myotubes, oleate incorporation into TAG increased
by 93%. When insulin was present, oleate incorporation into
TAG increased by 270% compared with controls in the absence
of insulin, and AICA riboside had no additional effect.
Effect of AICA riboside on hepatocyte and myocyte lipolysis
Others have reported that AMPK phosphorylates and inactivates
hormone-sensitive lipase, thereby decreasing adipocyte lipolysis
[10]. Hormone-sensitive lipase is also expressed in muscle, but
lipolysis in hepatocytes is catalysed by different lipases. Our





myotubes and cholesterol esters in hepatocyte
suspensions suggested that AMPK might inhibit the hydrolysis
of TAG and cholesterol esters. To test this prediction, we




myotube lipids with ["%C]oleate,
and then examined the effects of AICA riboside on lipid
hydrolysis. In hepatocytes, 27% of the labelled TAG was
hydrolysed during the 3 h chase (Figure 4A). Adding AICA
riboside to the chase media decreased ["%C]DAG by 37% and
increased ["%C]cholesterol ester by 46%, but had no effect on
labelling of TAG or phospholipids. These data indicate that the
AICA riboside-induced decreases in hepatocyte ["%C]TAG levels
(above) were due to decreased TAG biosynthesis. Furthermore,
the data also suggest that, in hepatocytes, distinct lipases
hydrolyse TAG and cholesterol esters, and AMPK regulates




myotubes, 66% of ["%C]TAG was hydrolysed during the 3 h
chase and AICA riboside inhibited TAG lipolysis by 47%
(Figure 4B). The decrease in myocyte ["%C]TAG in the control
compared with AICA riboside-treated cells was quantitatively
accounted for by a 21% increase (P! 0.01) in the amount of
"%C-label recovered from the chase media. Similarly to our
observation in hepatocytes, AICA riboside in the chase media
decreased myotube ["%C[DAG by 29%, but had no effect on the
labelled phospholipids.
AMPK inhibits GPAT activity in hepatocytes
In each of the cell or tissue types studied, AICA riboside
significantly decreased labelling of the lipid intermediate, DAG.
A decrease in labelled DAG could occur either by inactivating
one of the first steps in the pathway of DAG synthesis, or by
rapid use of DAG to synthesize TAG and phospholipid. Because
AICA riboside decreased TAG and, under certain conditions,
phospholipid synthesis, our data suggested that AICA riboside
inhibits the de noo pathway of glycerolipid synthesis. Fur-
thermore, the AMPK-mediated increase in fatty acid oxidation
could account for only a small percentage of the absolute
decrease in the amount of fatty acid esterified into complex
lipids. Our observation that AICA riboside inhibits fatty acid
incorporation into TAG, DAG and phospholipid, but not
cholesterol esters, suggests that AMPK might inhibit at an early
step in glycerolipid synthesis. The most probable target for
inhibition is the enzyme that catalyses the first and committed
step in glycerolipid biosynthesis, GPAT. Mammalian cells con-
tain two GPAT isoenzymes, one located in the outer mito-
chondrial membrane and the other in the endoplasmic reticulum
[17]. The mitochondrial isoenzyme comprises 30–50% of liver
GPAT activity, but less than 10% of GPAT activity in other
tissues [17]. The activities of these two isoenzymes can be
distinguished because only the endoplasmic reticulum (micro-
somal) GPAT is inactivated by NEM.
To determine whether AMPK inactivates the two GPAT
activities, we used hepatocytes. When hepatocytes are isolated by
collagenase perfusion, AMPK activity is initially very high, but
declines by 80% during a 60 min incubation [2]. Similarly, the
activities of AMPK substrates, ACC and HMG-CoA reductase,
are initially low and increase during this time. Therefore, to
determine whether similar changes occur for GPAT, we measured
GPAT activity in freshly isolated hepatocytes 30 min before
adding AICA riboside, and during the 60 min after adding AICA
riboside (Figure 5). In control cells, activities of mitochondrial
and microsomal GPAT isozymes increased 44% and 53%
respectively during the 90 min experiment. Incubating cells with
AICA riboside decreased mitochondrial GPAT activity by 29–
43% in a time-dependent manner (Figure 5A). The effect of
AICA riboside on mitochondrial GPAT was most pronounced
at 40 min, after which the activity in control cells also declined.
During the first 40 min after adding AICA riboside, microsomal
GPAT activity was unaffected (Figure 5B). However, after a
60 min incubation with AICA riboside, microsomal GPAT
decreased 35%. From these data, it appears that AMPK might
regulate both GPAT isoforms, but that inactivation of the
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Figure 5 Effect of AICA riboside on GPAT activities in isolated hepatocytes
Mitochondrial (A) and microsomal (B) GPAT activities were measured in total particulate
preparations isolated from hepatocytes incubated for 0–90 min. After a 30 min preincubation,
AICA riboside (AICAR ; 0.5 mM) was added to the incubation media (indicated by downward
arrows). Data are expressed as a percentage of the initial enzyme activities measured in
hepatocytes that were collected and frozen immediately after isolating the cells. Initial activities
were 0.233³0.045 nmol/mg per min and 0.547³0.064 nmol/mg per min for mitochondrial
and microsomal GPAT respectively. Values represent means³S.D. for three to six wells
collected during two separate incubations. *P ! 0.01 ; **P ! 0.001.
mitochondrial enzyme occurs more rapidly. These results were
corroborated by two additional experiments in which exposing
hepatocytes to 0.5 mM AICA riboside for both 15 and 30 min
decreased mitochondrial GPAT by 22–34%, without affecting
microsomal GPAT activity (results not shown).
Since AMPK inhibits ACC activity and consequently decreases
liver concentrations of malonyl-CoA, we investigated the possi-
bility that malonyl-CoA is a regulator of GPAT. Adding
concentrations of malonyl-CoA of 0.5–10.0 mM affected neither
mitochondrial nor microsomal GPAT activity (results not
shown).
To determine whether the effect of AICA riboside was similar




myocytes. In myotubes, microsomal GPAT activity was
0.51³0.06 nmol}mg per min, and was unaffected by a 1 h
incubation with AICA riboside. Because mitochondrial GPAT
activity accounted for only 10% of the low total GPAT activity
in these cells, it could not be measured reliably. The low
mitochondrial GPAT activity usually found in cultured cell lines
[17,28] might partly explain the observed differences in AICA
riboside’s effects on glycerolipid metabolism in hepatocytes
compared with myocytes.
Figure 6 Inhibition of mitochondrial GPAT activity by AMPK
Rat liver mitochondria (150 µg of protein) were incubated with AMPK1 or AMPK2 with or
without 1.3 mM ATP. After 10 or 30 min, aliquots were assayed for GPAT activity at 20, 30
and 40 µg of mitochondrial protein, as described in the Experimental section. Data are shown
from an experiment that was repeated three additional times with inhibitions ranging from
30–50%.
In order to determine the specificity of the effects of AICA
riboside, we measured the activities of DGAT, the activity
unique to TAG synthesis, and ACS, the activity required to
activate fatty acids for metabolism by both the oxidative and
synthetic pathways. In the same hepatocyte membrane
preparations in which GPAT assays had been performed,
activities of DGAT and ACS were 1.06³0.25 and 9.82³
0.61 nmol}mg per min respectively. Incubating cells for 5–60 min
with 0.5 mM AICA riboside had no effect on the activity of
either DGAT or ACS.
AMPK1 and AMPK2 inhibit mitochondrial GPAT activity
Recombinant AMPK1 and AMPK2 both inhibited liver mito-
chondrial GPAT 21% after 10 min and 40% after 30 min of
incubation (Figure 6). The amount of inhibition was identical for
AMPK1 and AMPK2. Inhibition was dependent on both time
and the presence of ATP. ATP alone or boiled AMPK had no
effect (results not shown). In a microsomal membrane prep-
aration that contained 12% NEM-resistant (mitochondrial)
GPAT, a 30 min incubation with AMPK inhibited approx. 4%
of the activity, consistent with inhibition of only the mito-
chondrial GPAT isoform (results not shown).
DISCUSSION
AMPK has been described as a cellular ‘ fuel gauge’ that is
activated when metabolic stresses deplete ATP. AMPK responds
to the increased cellular AMP:ATP ratio by inhibiting pathways
that use energy, and stimulating pathways that produce energy
[1]. In hepatocytes [29], adipocytes [10], myocytes [6] and perfused
muscle [9], AICA riboside, at the concentrations used in our
experiments, stimulates AMPK activity up to 12-fold without
changing cellular concentrations of ATP, AMP or ADP. We
used AICA riboside to provide evidence that AMPK inhibits the
synthesis of TAG, DAG and phospholipid. In both hepatocytes
and isolated skeletal muscle, AICA riboside decreased ["%C]oleate
incorporation into TAG, DAG and phospholipid by 45–95%
without inhibiting label incorporation into cholesterol esters.
AICA riboside also decreased [$H]glycerol incorporation into
these glycerolipids, suggesting that AMPK mediates inhibition
# 1999 Biochemical Society
790 D. M. Muoio and others
Scheme 1 Reciprocal regulation of fatty acid oxidation and TAG biosynthesis by AMPK
Within the cell, AICA ribonucleoside (AICAR) is phosphorylated to form ZMP, an AMP analogue that activates both AMPK and AMPK kinase (AMPKK). Activated AMPK phosphorylates and inactivates
ACC, thereby decreasing malonyl-CoA levels and relieving CPT1 inhibition. AMPK also phosphorylates and inactivates mitochondrial GPAT so that less lysophosphatidic acid is synthesized. Both
GPAT and CPT1 are intrinsic membrane proteins (shown schematically by oblong dot-filled boxes) whose active sites face the cytosolic surface of the outer mitochondrial membrane and can compete
for acyl-CoAs. The net effect of AMPK activation is to channel acyl-CoAs towards β-oxidation and away from glycerolipid biosynthesis. Plus or minus signs in parentheses indicate activatory or
inhibitory effects respectively. ER, endoplasmic reticulum ; PC, phosphatidylcholine ; PE, phosphatidylethanolamine.
of lipid synthesis de noo at an early step in the pathway of
glycerolipid biosynthesis.
Denoo synthesis of TAGand phospholipid involves a complex
multienzyme pathway with several common intermediates, in-
cluding DAG (Scheme 1). Since GPAT catalyses the first and
committed step in glycerolipid synthesis, and is believed to be
rate-limiting, it represents an obvious site for the regulation of
fatty acid esterification. Adding AICA riboside to rat hepatocyte
suspensions inhibited the activity of the mitochondrial, but not
the microsomal, GPAT activity. Furthermore, in isolated mito-
chondria, purified AMPK containing the α-1 or α-2 catalytic
subunits inhibited mitochondrial GPAT in both a time- and
ATP-dependent manner. These data suggest that the mito-
chondrial GPAT might be phosphorylated and inactivated by
AMPK. Indirect evidence from other laboratories had suggested
that mitochondrial GPAT is acutely regulated, and that in-
activation is associated with conditions that would favour GPAT
phosphorylation [30]. Analysis of the rat mitochondrial GPAT
cDNA sequence predicts four potential phosphorylation sites
that match the consensus motif recognized by AMPK (NCBI
PDB 2444459). Whether AMPK inhibits mitochondrial GPAT
by directly phosphorylating the enzyme or by phosphorylating
an intermediate regulatory protein remains to be determined.
AICA riboside’s effect as an activator of AMPK has been well
characterized in hepatocytes, and appears to be independent of
changes in other purine nucleotides [10,29]. Although small
amounts of the triphosphorylated derivative, ZTP, are formed in
hepatocytes, the metabolic consequences of increased cellular
ZTP are unknown, and, at 15 min when activation of AMPK is
maximal, the concentration of ZTP in hepatocytes is very low
(13%) compared with ATP [10]. Thus, since we observed AICA
riboside-mediated decreases in mitochondrial GPAT at early
time points, it is unlikely that the effect was non-specific and
related to ZTP accumulation. Our data showing that purified
AMPK inhibits mitochondrial GPAT activity strongly suggest
that AICA riboside’s effect to decrease TAG synthesis in muscle
and liver is due toAMPK-mediated inactivation of mitochondrial
GPAT. However, since AICA riboside also mimics the effects of
AMP on other energy-regulating enzymes, such as glycogen
phosphorylase [5] and fructose-1,6-bisphosphatase [31], we can-
not rule out the possibility that AICA riboside might also affect
TAG synthesis indirectly via mechanisms that are independent of
AMPK.
Because the specific activity of GPAT in skeletal muscle is very
low, we were unable to test directly the effects of AICA riboside
or AMPK on muscle GPAT activities. However, our study of
["%C]oleate partitioning in muscle implies that AICA riboside’s
effects are similar in muscle and liver. In isolated soleus muscle,
AICA riboside increased ["%C]oleate oxidation by 48–78%. This
increase corroborates a study in perfused rat hind-limb in which
AICA riboside-induced activation of AMPK stimulated fatty
acid oxidation 2.8-fold, together with a 75% decrease in muscle
ACC activity and a 50% decrease in malonyl-CoA [9]. To
quantify the net effect of AICA riboside on acyl-CoA par-
titioning, we divided the amount of fatty acid esterified into TAG
by the amount of fatty acid oxidized to CO
#
. When insulin was
present in the incubation media to promote lipogenesis, 15 times
more ["%C]oleate was esterified into TAG than was oxidized.
Adding AICA riboside to the media decreased this ratio by 78%,
clearly illustrating the marked effect of AMPK on fatty acid
partitioning between the oxidative and biosynthetic pathways.
These observations might have important physiological relevance
during endurance exercise, which stimulates muscle AMPK
activity and shifts muscle-substrate utilization in favour of fatty
acids.
Insulin-mediated suppression of muscle fatty acid oxidation is
believed to result from stimulation of ACC activity, thereby
increasing the malonyl-CoA concentration which would inhibit
CPT1 and, thus, fatty acid transport into mitochondria [32].
Although it is yet unclear how insulin increases fatty acid
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incorporation into TAG, in perfused rat liver, cardiomyocytes
and cultured adipocytes, insulin acutely activates GPAT [33–35].
In most of these studies, however, the mitochondrial and
microsomal isoenzymes were not differentiated. Because AICA





myocytes and isolated soleus muscle, AMPK might
counteract insulin ’s action on muscle fatty acid partitioning
via their common targets, ACC and mitochondrial GPAT.
Differences between myocytes and isolated soleus muscle in their
incorporation of fatty acid into TAG during incubation with
AICA riboside might be due to differences in the expressed
activities of GPAT, CPT1 and}or other enzymes, such as TAG
lipase, that determine muscle lipid metabolism.
Mitochondrial GPAT is developmentally, nutritionally and
hormonally regulated [36,37], but its precise role remains elusive
because mitochondria lack the enzymic machinery necessary to
synthesize glycerolipids beyond lysophosphatidic acid (Scheme
1) [30,38]. Thus lysophosphatidate must be transported from the
mitochondria to the endoplasmic reticulum, where TAG and
phospholipid biosynthesis occur [39]. Since mitochondrial GPAT
and CPT1 are both located on the outer mitochondrial mem-
brane, the mitochondrial isoform of GPAT is uniquely positioned
to compete directly with CPT1 for acyl-CoA substrates. It is
therefore tempting to speculate that, by converting acyl-CoA
into lysophophatidate, mitochondrial GPAT plays a pivotal role
in preventing fatty acids from undergoing β-oxidation. Regu-
lation of the relative activities of mitochondrial GPAT and CPT1
would thus control the branch point at which acyl-CoA substrates
are partitioned towards either oxidative or biosynthetic path-
ways. We propose that when cellular ATP levels are com-
promised, AMPK-mediated inactivation of mitochondrial
GPAT serves not only to conserve energy by inhibiting lipid
biosynthesis, but, by eliminating CPT1’s direct competitor for
acyl-CoA substrates, also potentiates fatty acid entry into
mitochondria.
This work was supported by HD19068 (RAC) and DK 35712 (LAW) from the National
Institutes of Health, a grant from the North Carolina Institute of Nutrition and a
predoctoral fellowship to D. M. M. from the American Heart Association–North
Carolina Affiliate. We thank Dr. J. Lemasters, Dr. Ting Qian and Steve Elmore for their
assistance with the hepatocyte isolations. We also thank Petra Schmaltz and Ping
Wang for their assistance with lipid analyses and enzyme assays.
REFERENCES
1 Hardie, D. G. and Carling, D. (1997) Eur. J. Biochem. 246, 259–273
2 Moore, F., Weekes, J. and Hardie, D. G. (1991) Eur. J. Biochem. 199, 691–697
3 Davies, S. P., Carling, D. and Hardie, D. G. (1989) Eur. J. Biochem. 86, 123–128
Received 8 September 1998/8 December 1998 ; accepted 11 January 1999
4 Carling, D. and Hardie, D. G. (1989) Biochim. Biophys. Acta 1012, 81–86
5 Young, M. E., Radda, G. K. and Leighton, B. (1996) FEBS Lett. 382, 43–47
6 Ponticos, M., Lu, Q. L., Morgan, J. E., Hardie, D. G., Partridge, T. A. and Carling, D.
(1998) EMBO 17, 1688–1699
7 McGarry, J. D., Mills, S. E., Long, C. S. and Foster, D. W. (1983) Biochem. J. 214,
21–28
8 Velasco, G., Geelen, M. J. H. and Guzma! n, M. (1997) Arch. Biochem. Biophys. 337,
169–175
9 Merrill, G. F., Kurth, E. J., Hardie, D. G. and Winder, W. W. (1997) Am. J. Physiol.
273, E1107–E1112
10 Corton, J. M., Gillespie, J. G., Hawley, S. A. and Hardie, D. G. (1995) Eur. J.
Biochem. 229, 558–565
11 Berry, M. N. and Friend, D. S. (1969) J. Cell Biol. 43, 506–520
12 Bligh, E. G. and Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911–917
13 Glatz, J. F. and Veerkamp, J. H. (1982) Biochim. Biophys. Acta 713, 230–239
14 Igal, R. A. and Coleman, R. A. (1996) J. Biol. Chem. 271, 16644–16651
15 Fleischer, S., McIntyre, J. O. and Vidal, J. C. (1979) Methods Enzymol. 55, 32–39
16 Schlossman, D. M. and Bell, R. M. (1976) J. Biol. Chem. 251, 5738–5744
17 Bell, R. M. and Coleman, R. A. (1980) Annu. Rev. Biochem. 49, 459–487
18 Coleman, R. A. and Bell, R. M. (1976) J. Biol. Chem. 251, 4537–4543
19 Banis, R. J. and Tove, S. B. (1974) Biochim. Biophys. Acta 348, 210–220
20 Dyck, J. R. B., Gao, G., Widmer, J., Stapleton, D., Fernandez, C. S., Kemp, B. E. and
Witters, L. A. (1996) J. Biol. Chem. 271, 17798–17803
21 Labarca, C. and Paigen, K. (1980) Anal. Biochem. 102, 344–352
22 Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) J. Biol. Chem.
193, 265–275
23 Chang, Y.-Y. and Kennedy, E. P. (1967) J. Lipid Res. 8, 447–455
24 Merrill, A. H. J., Gidwitz, S. and Bell, R. M. (1982) J. Lipid Res. 23, 1368–1373
25 Muoio, D. M., Dohm, G. L., Fiedorek, F. T., Tapscott, E. B. and Coleman, R. A. (1997)
Diabetes 46, 1360–1363
26 Bennett, A. M. and Tonks, N. K. (1997) Science 278, 1288–1291
27 Rump, R., Buhlmann, C., Borchers, T. and Spener, F. (1996) Eur. J. Cell Biol. 69,
135–142
28 Haldar, D. and Vancura, A. (1992) Methods Enzymol. 209, 64–72
29 Henin, N., Vincent, M. F. and Van den Berghe, G. (1996) Biochim. Biophys. Acta
1290, 197–203
30 Bell, R. M. and Coleman, R. A. (1983) in The Enzymes, Vol. 16 (Boyer, P. D., ed.),
pp. 87–112, Academic Press, New York
31 Vincent, M. F., Marangos, P. J., Gruber, H. E. and Van den Berghe, G. (1991)
Diabetes 40, 1259–1266
32 Saha, A. K., Vavvas, D., Kurowski, T. G., Apazidis, A., Witters, L. A., Shafrir, E. and
Ruderman, N. B. (1997) Am. J. Physiol. 272, E641–E648
33 Vila, M. C., Milligan, G., Standaert, M. L. and Farese, R. V. (1990) Biochemistry 29,
8735–8740
34 Vila, M. C. and Farese, R. V. (1991) Arch. Biochem. Biophys. 284, 366–368
35 Bates, E. J., Topping, D. L., Soorana, S. P., Saggerson, D. and Mayes, P. A. (1977)
FEBS Lett. 84, 225–228
36 Coleman, R. A. and Haynes, E. B. (1983) J. Biol. Chem. 258, 450–465
37 Shin, D.-H., Paulauskis, J. D., Moustaid, N. and Sul, H. S. (1991) J. Biol. Chem.
266, 23834–23839
38 Hjelmstad, R. H. and Bell, R. M. (1991) Biochemistry 30, 1731–1739
39 Vancura, A. and Haldar, D. (1992) J. Biol. Chem. 267, 14353–14359
# 1999 Biochemical Society
